-
Je něco špatně v tomto záznamu ?
Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R)
V. Hainer, I. Aldhoon Hainerová, M. Kunešová, R. Taxová Braunerová, H. Zamrazilová, B. Bendlová
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- alfa-MSH farmakologie MeSH
- celogenomová asociační studie MeSH
- cílená molekulární terapie MeSH
- látky proti obezitě farmakologie MeSH
- lidé MeSH
- mutace * MeSH
- obezita farmakoterapie genetika metabolismus MeSH
- receptor melanokortinový typ 4 genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Leptin-melanocortin pathway plays an essential role in the body weight regulation. Enhanced melanocortin signaling in the hypothalamus results in both decreased food intake and increased energy expenditure. The discovery of monogenic obesities with dysfunction of melanocortin-4 receptor (MC4R) greatly contributed to understanding of energy balance regulation. This review presents phenotypical characterization and prevalence of the MC4R gene mutations. Genome-wide association studies revealed that MC4R gene is significantly related not only to monogenic obesities but also to common obesity. An interaction of variants in the MC4R gene with fat mass and obesity associated (FTO) gene significantly increases the risk for obesity, particularly in adolescence. On the other hand, about 15 % of the MC4R gene variants result in a gain of function that protects against obesity and is associated with favorable metabolic profile. Long-term attempts to activate the MC4R have recently been finalized by a discovery of setmelanotide, a novel specific MC4R agonist that is devoid of untoward cardiovascular side-effects. The employment of specific MC4R agonists may open new horizons not only in the treatment of rare monogenic obesities but also in some common obesities where stimulation of MC4R could be achieved.
Department of Molecular Endocrinology Institute of Endocrinology Prague Czech Republic
Obesity Management Center Institute of Endocrinology Prague Czech Republic
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21022246
- 003
- CZ-PrNML
- 005
- 20210914152208.0
- 007
- ta
- 008
- 210902s2020 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934512 $2 doi
- 035 __
- $a (PubMed)33094623
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hainer, Vojtěch, $d 1944- $7 jn19990209207 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
- 245 10
- $a Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R) / $c V. Hainer, I. Aldhoon Hainerová, M. Kunešová, R. Taxová Braunerová, H. Zamrazilová, B. Bendlová
- 504 __
- $a Literatura
- 520 9_
- $a Leptin-melanocortin pathway plays an essential role in the body weight regulation. Enhanced melanocortin signaling in the hypothalamus results in both decreased food intake and increased energy expenditure. The discovery of monogenic obesities with dysfunction of melanocortin-4 receptor (MC4R) greatly contributed to understanding of energy balance regulation. This review presents phenotypical characterization and prevalence of the MC4R gene mutations. Genome-wide association studies revealed that MC4R gene is significantly related not only to monogenic obesities but also to common obesity. An interaction of variants in the MC4R gene with fat mass and obesity associated (FTO) gene significantly increases the risk for obesity, particularly in adolescence. On the other hand, about 15 % of the MC4R gene variants result in a gain of function that protects against obesity and is associated with favorable metabolic profile. Long-term attempts to activate the MC4R have recently been finalized by a discovery of setmelanotide, a novel specific MC4R agonist that is devoid of untoward cardiovascular side-effects. The employment of specific MC4R agonists may open new horizons not only in the treatment of rare monogenic obesities but also in some common obesities where stimulation of MC4R could be achieved.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a látky proti obezitě $x farmakologie $7 D019440
- 650 _2
- $a celogenomová asociační studie $7 D055106
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a cílená molekulární terapie $7 D058990
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a obezita $x farmakoterapie $x genetika $x metabolismus $7 D009765
- 650 _2
- $a receptor melanokortinový typ 4 $x genetika $x metabolismus $7 D044105
- 650 _2
- $a alfa-MSH $x farmakologie $7 D000521
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Aldhoon Hainerová, Irena, $d 1978- $7 xx0062316 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic $u Department of Pediatrics, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Kunešová, Marie, $d 1951- $7 jn19990209456 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Braunerová, Radka $7 xx0092176 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Zamrazilová, Hana $7 xx0092178 $u Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Bendlová, Běla, $d 1962- $7 jo20000074069 $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, Suppl 2 (2020), s. S245-S254
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33094623 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20210902 $b ABA008
- 991 __
- $a 20210908143300 $b ABA008
- 999 __
- $a ok $b bmc $g 1697043 $s 1142720
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 69 $c Suppl 2 $d S245-S254 $e 20200930 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20210902